Financial statements J.chodacki, A.misztal, Medica
Balance sheet data of J.CHODACKI, A.MISZTAL, MEDICA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 20 264 759,31 | 20 944 989,28 | 100 664 918,25 | 156 404 300,83 | 51 569 772,84 | 64 775 474,65 |
A. Fixed assets | 2 739 868,40 | 2 611 332,74 | 5 396 300,17 | 7 378 173,95 | 10 425 351,91 | 22 282 625,64 |
B. Current assets | 17 524 890,91 | 18 333 656,54 | 95 268 618,08 | 149 026 126,88 | 41 144 420,93 | 42 492 849,01 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 20 264 759,31 | 20 944 989,28 | 100 664 918,25 | 156 404 300,83 | 51 569 772,84 | 64 775 474,65 |
A. Equity | 17 516 186,56 | 18 273 593,12 | 83 684 521,96 | 142 829 899,80 | 37 106 658,63 | 31 025 146,60 |
B. Liabilities and provisions for liabilities | 2 748 572,75 | 2 671 396,16 | 16 980 396,29 | 13 574 401,03 | 14 463 114,21 | 33 750 328,05 |
I. Long-term liabilities | 712 500,00 | 562 500,00 | 1 109 266,71 | 291 913,21 | 233 533,50 | 0,00 |
II. Short-term liabilities | 2 036 072,75 | 2 108 896,16 | 15 871 129,58 | 13 282 487,82 | 14 229 580,71 | 27 547 486,38 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.